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Editors: Anton N. Sidawy and Bruce A. PerlerFamily history of aortic disease predicts disease patterns
and progression and is a signiﬁcant inﬂuence on
management strategies for patients and their relatives
Chase R. Brown, Roy K. Greenberg, Shen Wong, Matthew
Eagleton, Tara Mastracci, Adrian V. Hernandez, Christina M.
Rigelsky, Rocio Moran
Background: While a positive family history (FH) is a known
risk factor for developing an aneurysm, its association with
the extent of disease has not been established. We eval-
uated the inﬂuence of a FH of aortic disease with respect to
the pattern and distribution of aortic aneurysms in a given
patient.
Methods and Results: From November 1999 to November
2011, 1263 patients were enrolled in physician-sponsored
endovascular device trials to treat aortic aneurysms. Of the
555 patients who were alive and returning for follow-up,
we obtained 426 (77%) family histories. Three-dimensional
imaging studies were used to identify the presence of
aneurysms; 36% (155/426) of patients had a FH of aortic
aneurysms and 5% (21/155) had isolated intracranial an-
eurysms. A logistic regression model was used to compare
aortic morphology between patients with a positive or
negative FH for aneurysms. Patients with a positive FH of
aortic aneurysms were younger at their initial aneurysm
(63 vs 70 years; P < .0001), more frequently had proximal
aortic involvement (root: odds ratio [OR], 5.4; P < .0001;
ascending: OR, 2.9; P < .001; thoracic: OR, 2.2; P = .01)
with over 50% of FH patients ultimately developing su-
prarenal aortic involvement (P = .0001) and had a greater
incidence of bilateral iliac artery aneurysm (OR, 1.8; P =
.03).
Conclusions: FH is an important tool that provides insight
into the expected behavior of the untreated aorta and has
signiﬁcant implications for the development of treatment
strategies. These ﬁndings should be used to guide patient's
management with regard to treatment, follow-up para-
digms, genetic testing, and screening of other family
members.A case-matched validation study of anatomic severity
grade score in predicting reinterventions after
endovascular aortic aneurysm repair
Patricia G. Johnson, Candice R. Chipman, Sadaf S. Ahanchi,
Jung H. Kim, David J. Dexter, Jean M. Panneton*Full articles available online at www.jvascsurg.org
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http://dx.doi.org/10.1016/S1078-5884(13)00483-8Background: In 2002, the Society for Vascular Surgery cre-
ated the anatomic severity grading (ASG) score to classify
abdominal aortic aneurysms (AAAs). Our objective was to
identify the predictive capability and cutoff value of pre-
operative ASG score for reintervention after endovascular
aneurysm repair (EVAR).
Methods: We completed a retrospective review of AAA
patients treated with elective EVAR from 2007 through
2011. Patients who had reinterventions as well as preop-
erative M2S (M2S Inc, West Lebanon, NH) three-dimen-
sional reconstructions were identiﬁed and compared with
a case-matched control group of patients without reinter-
vention. ASG component scores (neck, aortic, and iliac) and
total ASG scores were calculated using M2S software.
Results: Of the 623 patients treated with EVAR, 79 (13%)
had reinterventions of which 45 had preoperative M2S
three-dimensional reconstructions available for ASG score
calculation. The reintervention group (mean age, 74  8;
80% male) had a mean ASG score of 18  5 (range, 8-30)
compared with a cohort of 45 EVAR patients (mean age, 74
 7; 80% male) who had a mean ASG score of 13  4
(range, 6-21; P < .0001). The mean AAA diameter for all
patients was 52 mm  ̆ 14 and was not signiﬁcantly dif-
ferent between the groups.
After area under the receiver-operating curve analysis,
an ASG score of 17 was highly predictive for reinterven-
tion (area = 0.8; sensitivity = 60%; speciﬁcity = 78%;
positive predictive value = 73%; negative predictive value
= 66%). An ASG score of 13 was highly predictive for
freedom from reintervention (sensitivity = 93%; speciﬁcity
= 47%; positive predictive value = 64%; negative predic-
tive value = 88%). The lowest ASG score that yielded
a 100% reintervention rate was 22. The majority of rein-
terventions fell into three categories: proximal extension
cuff (n = 18; 40%), distal extension limb (n = 7; 16%), and
type II endoleak embolization (n = 13; 29%). Those that
received proximal extensions had signiﬁcantly higher
mean total ASG score (19 vs 15; P = .0005), mean neck
score (3.28 vs 2.36; P = .047), and mean aorta score (7.39
vs 2.36; P = .004). Those that received distal extensions
had a signiﬁcantly higher mean iliac score (9.00 vs 6.86; P
= .013), and those that required an embolization had
a signiﬁcantly higher mean aorta branch score (1.92 vs
1.19; P = .017).
Conclusions: Preoperative total ASG score strongly pre-
dicts reintervention after EVAR. Use of a cutoff ASG value
predictive of prohibitive reintervention rates could help
guide the decision between endovascular vs open AAA
repair.
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with multiple overlapping uncovered stents
Yong-Xue Zhang, Qing-Sheng Lu, Jia-Xuan Feng, Zhi-Qing
Zhao, Jun-Min Bao, Rui Feng, Xiang Feng, Zai-Ping Jing
Objective: This study aims at evaluating the safety and ef-
ﬁcacy of a porous stent system consisting of multiple
overlapping uncovered stents in the treatment of complex
aortic aneurysms with vital branches.
Methods: Data of all patients with aortic aneurysms treated
in our center with multiple overlapping uncovered stents
between February 2010 and December 2011 were retro-
spectively reviewed. Preoperative characteristics, intra-
operative details, and follow-up outcomes were
documented. Technical success was deﬁned as successful
deployment of the stents to target locations without pro-
cedure-related complications. Clinical success was charac-
terized by complete shrinkage or stabilization of the
aneurysm, preservation of vital branches, and absence of
major complications. Patients were grouped, according to
rapidity of aneurysm thrombosis, into fast-thrombosis
group (complete thrombosis of aneurysmal sac was ach-
ieved in 6 months) and a delayed-thrombosis group (>6
months required for complete thrombosis). Possible factors
affecting the speed of thrombosis were analyzed statistically
with the Fisher exact test and the t-test.
Results: This porous stent system was used to treat 34
patients (23 men, 11 women; mean age, 65.7 years).
Technical success was achieved in all patients (100%).
Regular follow-up over 6 months was achieved in 29 pa-
tients (mean length of follow-up, 11.4 months). Complete
thrombosis of the aneurysm sac within 12 months was
observed in 24 patients (83%). Aneurysm shrinkage was
documented in seven patients (24%) and stabilization in 21
(72%). All branch arteries covered by bare stents stayed
patent during follow-up. The overall clinical success rate
reached 97% in the follow-up group. Risk factors for delayed
thrombosis included fewer stents implanted (P ¼ .013),
longer sac entrance (P ¼ .043), and use of antiplatelet
medication (P ¼ .040).
Conclusions: An alternative method of management of
complicated aortic aneurysm appears to be feasible using
overlapping bare stents, which may prevent aneurysm
growth while preserving vital branches. The short-term out-
come of our study seems encouraging but is not sufﬁcient to
draw a robust conclusion. Further hemodynamic and clinical
studies are warranted to evaluate long-term efﬁcacy.Clinical signiﬁcance of type II endoleaks after thoracic
endovascular aortic repair
Moritz S. Bischoff, Philipp Geisbüsch, Drosos Kotelis, Mat-
thias Müller-Eschner, Alexander Hyhlik-Dürr, Dittmar Böckler
Background: To evaluate the clinical signiﬁcance of type II
endoleaks (ELII) after thoracic endovascular aortic repair
(TEVAR).
Methods: From January 1997 to June 2012, a total of 344
patients received TEVAR in our institution. ELII wasdiagnosed in 30 patients (8.7%; 13 males; median age:
65 years, range: 24 to 84 years), representing the study
population of this retrospective, single-center analysis.
Mean follow-up was 29.5 months (range, 8 months to
9.5 years).
Results: Primary ELII was observed in all but two cases (28/
30; 93.3%). The most common sources of ELII were the left
subclavian artery (LSA; 13/30; 43.3%) and intercostal/
bronchial vessels (13/30; 43.3%), followed by visceral ar-
teries (4/30; 13.4%). Overall mortality was 33.3% (10/30).
ELII-related death (secondary rupture) was observed in 20%
(2/10). Reintervention (RI) procedures for ELII were per-
formed in 9 of 30 patients (30.0%); 5 of 9 (55.6%) in
cases with ELII via the LSA. Indications for RI were diameter
expansion in ﬁve and extensive leakage in four cases.
Treatment was successful in ﬁve patients (55.6%) but failed
in four cases (44.4%). In 12 of 21 (57.1%) untreated pa-
tients, ELII sealed during follow-up. In conservatively trea-
ted patients, an increase in aortic diameter has been only
observed in a patient with secondary ELII.
Conclusions: The results presented herein suggest that the
clinical impact of ELII after TEVAR must not be under-
estimated. Albeit a transient ﬁnding in most cases, ELII is
associated with a relevant RI rate, particularly in cases
involving the LSA. RI seems indicated in patients with
increasing aortic diameter and/or extensive leakage. Careful
surveillance of all patients with ELII is recommended.The effect of surgeon’s specialty and volume on the
perioperative outcome of carotid endarterectomy
Ali F. AbuRahma, Patrick A. Stone, Mohit Srivastava, Ste-
phen M. Hass, Albeir Y. Mousa, L. Scott Dean, John E.
Campbell, Benny Y. Chong
Background: Several studies have demonstrated better
outcomes for carotid endarterectomy (CEA) at high-volume
hospitals and providers. However, only a few studies have
reported on the impact of surgeons’ specialty and volume
on the perioperative outcome of CEA.
Methods: This is a retrospective analysis of CEA during
a recent 2-year period. Surgeons’ specialties were classiﬁed
according to their Board specialties into general surgeons
(GS), cardiothoracic surgeons (CT), and vascular surgeons
(VS). Surgeons’ annual volume was categorized into low
volume (<10 CEAs), medium volume (10 to <30 CEAs), and
high volume (30 CEAs). The primary outcome was 30-day
perioperative stroke and/or death; however, other periop-
erative complications were analyzed. Both univariate and
multivariate analyses were done to predict the effect of
specialty/volume and any other patient risk factors on
stroke outcome.
Results: Nine hundred and ﬁfty-three CEAs were performed
by 24 surgeons: 122 by seven GS, 383 by 13 CT, and 448 by
4 VS. Patients’ demographics/clinical characteristics were
similar between specialties, except the incidence of coro-
nary artery disease, which was higher for CT (P < .0001).
The indications for CEA were symptomatic disease in 38%
Abstracts 391for VS, 31% for GS, and 23% for CT (P < .0001). The peri-
operative stroke and death rates were 4.1%, 2.9%, and 1.3%
for GS, CT, and VS, respectively (P ¼ .126). A subgroup
analysis showed that the perioperative stroke rates for
symptomatic patients were 5.3%, 2.3%, and 2.3% (P ¼ .511)
and for asymptomatic patients were 3.6%, 3%, and 0.72%
(P ¼ .099) for GS, CT, and VS, respectively. Perioperative
stroke rates were signiﬁcantly higher for nonvascular sur-
geons (GS and CT combined) vs VS in asymptomatic pa-
tients (3.2% vs 0.72%; P ¼ .033). Perioperative stroke/death
was also signiﬁcantly lower for high-volume surgeons: 1.3%
vs 4.1% and 4.3% for medium- and low-volume surgeons
(P ¼ .019) (1.3% vs 4.15% for high vs low/medium com-
bined; P ¼ .005). More CEAs were done for asymptomatic
patients in the low/medium-volume surgeons (78%) vs
high-volume surgeons (64%; P < .0001) with a stroke rate of
4.6% for low/medium-volume surgeons vs 0.51% for high-
volume surgeons (P ¼ .0005). A univariate logistic analysis
showed that the odds ratio of having a perioperative stroke
was 0.3 (95% conﬁdence interval [CI], 0.13-0.73; P ¼.008)
for high-volume surgeons vs low/medium-volume surgeons,
0.4 (95% CI, 0.16-1.07; P ¼ .069) for VS vs CT/GS and 0.2
(95% CI, 0.06-0.45; P ¼ .0004) when patching was used. A
multivariate analysis showed that the odds ratio of having
a perioperative stroke for CT VS was 2.1 (95% CI, 0.71-5.92;
P ¼ .183); for GS vs VS, 1.8 (95% CI, 0.49-6.90; P ¼ .3709);
for low-volume surgeons (vs high-volume) 3.4 (95% CI, 0.96-
11.77; P ¼ .0581); medium- vs high-volume surgeons 2.2
(95% CI, 0.75-6.42; P ¼ .1509).
Conclusions: High-volume surgeons had signiﬁcantly better
perioperative stroke/death rates for CEA than low/medium-
volume surgeons. Perioperative stroke/death rates were
also higher for nonvascular surgeons in asymptomatic
patients.Drug-coated balloon angioplasty after directional
atherectomy improves outcome in restenotic
femoropopliteal arteries
Sebastian Sixt, Oscar Gerardo Carpio Cancino, András Treszl,
Ulrich Beschorner, Roland Macharzina, Aljoscha Rastan,
Hans Krankenberg, Franz-Josef Neumann, Thomas Zeller
Background: Restenosis remains an unresolved problem
despite different treatment modalities and new stent
technology in femoropopliteal arteries. No standard therapy
has proven to provide acceptable outcome data for this
entity. Directional atherectomy alone did not result in sat-
isfactory long-term patency rates. The outcome might be
improved in conjunction with drug-coated balloon
angioplasty.
Methods: In this retrospective study, restenotic lesions of
the femoropopliteal arteries were treated with directed
atherectomy in 89 lesions of consecutive patients (58%
male; mean age, 69  11 years). All patients received
adjunctive treatment with conventional balloon percuta-
neous angioplasty (PTA; n ¼ 60) or drug-coated balloon
angioplasty (DCB; n ¼ 29).Results: Lesion location was in the stent (DCB [n ¼ 27] vs
PTA [n ¼ 36]) and in native restenotic vessels (DCB [n ¼ 2]
vs PTA [n ¼ 25]). The 1-year Kaplan-Meier freedom from
restenosis estimates (95% conﬁdence intervals) in the DCB
and PTA groups were 84.7% (70.9%-98.5%) and 43.8%
(30.5%-57.1%), respectively. In a multivariable Cox model
for restenosis, DCB treatment had a hazard ratio (95%
conﬁdence interval) of 0.28 (0.12-0.66; P ¼ .0036) com-
pared with the PTA group. In the multivariable model for
procedural success, the effect of treatment did not differ
between PTA and DCB (P ¼ .134).
Conclusions: The combination of directed atherectomy with
adjunctive DCB is associated with a better event-free sur-
vival at 12 months of follow-up compared with PTA after
directed atherectomy.Early management of pediatric vascular injuries through
humanitarian surgical care during U.S. military operations
Anahita Dua, Katherine C. Via, MAJ Peter Kreishman, COL
(ret) John F. Kragh, Philip C. Spinella, Bhavin Patel, COL (ret)
David L. Gillespie, COL Peter Mahoney, LTC (P) Charles J. Fox
Background: The objective of this report is to describe our
experience of pediatric vascular injuries in a U.S. military
combat support hospital in Baghdad, Iraq. A retrospective
study was designed using Joint Theater Trauma Registry
(JTTR) records in order to evaluate the pediatric (age <18
years) population presenting with vascular trauma to
a combat hospital in Baghdad, Iraq between April 2006 and
August 2008. Demographic data comprised casualty, age,
gender, and mechanism of injury. Physiologic data included
presenting vital signs (rectal temperature, blood pressure,
and heart rate), arterial pH, base deﬁcit, hemoglobin (g/dL),
and international normalized ratio.
Results: Twenty-ﬁve children, median age 14 years (range,
5-17 years), median weight 48 kg (range, 15-80 kg) sus-
tained 18 (72%) blast and 7 (28%) gunshot wounds. The
mean Injury Severity Score was 25  16.2. The median
operative time for the vascular repairs was 189 minutes
(range, 41-505 minutes). Patients were tachycardic (mean 
standard deviation, 136  29 bpm), hypotensive (109/63 
29/19 mm Hg), and acidemic (pH 7.26  0.07; BD -5.57 
5.1 mEq/L) on arrival to the emergency department and
were physiologically improved upon admission to the
intensive care unit 3 hours later. Repair techniques were
ligation (14; 39%), saphenous graft (11; 31%), lateral suture
(7; 19%), end anastomosis (2; 5%), patch (1; 3%), and
thrombectomy (1; 3%). Twenty-four hour mean transfusion
requirements included crystalloid 102 mL/kg (range, 19-
253), transfused blood 47 mL/kg (range, 0-119), fresh frozen
plasma 14 mL/kg (range, 0-68), and apheresis platelets
(1.2  3.68 units). Over a follow-up of 22  5.5 days, the
amputation-free survival was 80%.
Conclusions: This is the largest reported wartime series to
demonstrate in children that damage control resuscitation
despite high injury severity permits simultaneous limb
salvage.
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endovascular procedures and improves patient safety
Melissa L. Kirkwood, Gary M. Arbique, Jeffrey B. Guild,
Carlos Timaran, Jayer Chung, Jon A. Anderson, R. James
Valentine
Objective: Complex endovascular procedures such as
fenestrated endovascular aneurysm repair (FEVAR) are
associated with higher radiation doses compared with other
ﬂuoroscopically guided interventions (FGIs). The purpose of
this study was to determine whether surgeon education on
radiation dose control can lead to lower reference air kerma
(RAK) and peak skin dose (PSD) levels in high-dose
procedures.
Methods: Radiation dose and operating factors were
recorded for FGI performed in a hybrid room over a 16-
month period. Cases exceeding 6 Gy RAK were investigated
according to institutional policy. Information obtained from
these investigations led to surgeon education focused on
reducing patient dose. Points addressed included increasing
table height, utilizing collimation and angulation, decreasing
magniﬁcation modes, and maintaining minimal patient-to-
detector distance. Procedural RAK doses and operating
factors were compared 8 months pre- (group A) and 8
months post- (group B) educational intervention using
analysis of variance with Tukey pairwise comparisons and t-
tests. PSD distributions were calculated using custom soft-
ware employing input data from ﬂuoroscopic machine logs.
Results: Of 447 procedures performed, 300 FGIs had sufﬁ-
cient data to be included in the analysis (54% lower ex-
tremity, 11% thoracic endovascular aneurysm repair, 10%cerebral, 8% FEVAR, 7% endovascular aneurysm repair, 5%
visceral, and 5% embolization). Twenty-one cases were
investigated for exceeding 6 Gy RAK. FEVAR comprised 70%
of the investigated cases and had a signiﬁcantly higher
median RAK dose compared with all other FGIs (P < .0001).
There was no difference in body mass index between
groups A and B; however, increasing body mass index was
an indicator for increased RAK. PSD calculations were per-
formed for the 122 procedures that focused on the thorax
and abdomen (group A, 80 patients; group B, 42 patients).
Surgeon education most strongly affected table height, with
an average table height elevation of 10 cm per case after
education (P < .0001). The dose index (PSD/RAK ratio) was
used to track changes in operating practices, and it
decreased from 1.14 to 0.79 after education (P < .0001).
These changes resulted in an estimated 16% reduction in
PSD. There was a trend toward a decrease in patient to
detector distance, and the use of collimation increased from
25% to 40% (P < .001) for all cases; however, these did not
result in a decrease in PSD. The number of cases that
exceeded 6 Gy RAK did not change after education; how-
ever, the proportion of non-FEVAR cases that exceeded 6 Gy
decreased from 40% to 20%.
Conclusions: Surgeon education on the appropriate use of
technical factors during FGIs improved operating practice,
reduced patient radiation dose, and decreased the number
of non-FEVAR cases that exceeded 6 Gy. It is essential
that vascular surgeons be educated in best operating
practices to lower PSD; nonetheless, FEVAR remains a high-
dose procedure.
